齐明,男,博士。2018年毕业于暨南大学药学专业,获学士学位。2023年毕业于暨南大学中药药理学专业,获博士学位。2023年进入暨南大学临床医学博士后流动站进行博士后研究。已发表SCI论文16篇,其中以(共同)第一作者发表的SCI论文5篇。参与国家自然科学基金2项、广东省自然科学基金2项。申请中国发明专利2项。
研究方向:
周细胞介导肿瘤耐药和转移的作用机制研究以及创新药物的研究开发。
获奖情况:1.研究生国家奖学金
2.广东省研究生学术论坛-药学分论坛口头汇报一等奖
3.广东省第八届/第九届“互联网+”大学生创新创业大赛铜奖
4.暨南大学优秀毕业研究生
代表性论文:
[1]Qi M#, Fan SR#, Huang MH#, Pan JH, Li Y, Miao Q, Lyu WY, Li XB, Deng LJ, Qiu SH, Liu TZ, Deng WQ, Chu XD, Jiang C, He WZ, Xia LP, Yang YL, Hong J, Qi Q, Yin WQ, Liu XN, Shi CZ, Chen MF*, Ye WC*, Zhang DM*. Targeting FAPα-expressing hepatic stellate cells overcomes resistance to anti-angiogenics in colorectal cancer liver metastasis models. J Clin Invest, 2022 Aug 11;e157399.(IF=15.9)
[2] Huang MH#, Qi M#, Yang HY#, Peng Z, Chen SG, Liang MC, Hu YZ, Deng LJ*, Hu M*. Noninvasive strategies for the treatment of tiny liver cancer: integrating photothermal therapy and multimodality imaging EpCAM-guided nanoparticles. ACS Appl Mater & Interfaces, 2023, 15(18):21843-21853.(IF=9.5)
[3] Deng LJ#, Qi M#, Peng QL, Chen MF, Qi Q, Zhang JY, Yao N, Huang MH, Li XB, Peng YH, Liu JS, Fu DR, Chen JX, Ye WC*, Zhang DM*. Arenobufagin induces MCF-7 cell apoptosis by promoting JNK-mediated multisite phosphorylation of Yes-associated protein. Cancer Cell Int, 2018, 18:209.(IF=5.8)
[4] Deng LJ#, Qi M#, Li N#, Lei YH, Zhang DM, Chen JX*. Natural products and their derivatives: promising modulators of tumor immunotherapy. J Leukoc Biol, 2020, 108(2): 493-508.(IF=5.5)
[5] Gan H#, Qi M#, Chan C#, Leung P, Ye GN, Lei YH, Liu AA, Xue FF, Liu DD, Ye WC, Zhang DM, Deng LJ*, Chen JX*. Digitoxin inhibits HeLa cell growth through the induction of G2/M cell cycle arrest and apoptosis in vitro and in vivo. Int J Oncol, 2020, 57(2): 562-573.(IF=5.2)